title: An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
abstract: A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal cellular form (PrPC) to the disease-specific form (PrPSc). The transition from PrPC to PrPSc involves a major conformational change, resulting in amorphous protein aggregates and fibrillar amyloid deposits with increased beta-sheet structure. Using recombinant PrP refolded into a beta-sheet-rich form (beta-PrP) we have studied the fibrillization of beta-PrP both in solution and in association with raft membranes. In low ionic strength thick dense fibrils form large networks, which coexist with amorphous aggregates. High ionic strength results in less compact fibrils, that assemble in large sheets packed with globular PrP particles, resembling diffuse aggregates found in ex vivo preparations of PrPSc. Here we report on the finding of a beta-turn-rich conformation involved in prion fibrillization that is toxic to neuronal cells in culture. This is the first account of an intermediate in prion fibril formation that is toxic to neuronal cells. We propose that this unusual beta-turn-rich form of PrP may be a precursor of PrPSc and a candidate for the neurotoxic molecule in prion pathogenesis.
authors.affiliation: Department of Biological Sciences, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK.
authors.forename: Jurate
authors.initials: J
authors.lastname: Kazlauskaite
authors.forename: Anna
authors.initials: A
authors.lastname: Young
authors.forename: Catherine E
authors.initials: CE
authors.lastname: Gardner
authors.forename: Julie V
authors.initials: JV
authors.lastname: Macpherson
authors.forename: Catherine
authors.initials: C
authors.lastname: Vénien-Bryan
authors.forename: Teresa J T
authors.initials: TJ
authors.lastname: Pinheiro
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects*; D006224:Cricetinae; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D008647:Mesocricetus; D009097:Multienzyme Complexes / Q000737:chemistry / Q000494:pharmacology; D009447:Neuroblastoma / Q000473:pathology*; D009474:Neurons / Q000187:drug effects* / Q000473:pathology*; D009498:Neurotoxins / Q000737:chemistry / Q000494:pharmacology; D011328:Prions / Q000737:chemistry* / Q000494:pharmacology* / Q000648:ultrastructure; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D051381:Rats; D012995:Solubility; D013329:Structure-Activity Relationship
chemical_list: D009097:Multienzyme Complexes; D009498:Neurotoxins; D011328:Prions